U.S. Markets closed

GTX Inc. (GTXI) Worth Watching: Stock Rises 7.2%

Zacks Equity Research

GTX Inc. (GTXI) was a big mover last session, as the company saw its shares rise over 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the trend for the company since Dec 23, as the stock is now trading above the volatile price range of $1.64 and $1.75.

This biopharmaceutical company has seen four positive estimate revisions in the last 60 days, and the Zacks Consensus Estimate has also moved higher over the same period. This implies more solid trading ahead for the company. So make sure to keep an eye on this stock going forward to see if yesterday’s sharp climb can turn into more strength down the road.

GTX Inc. currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Better-ranked stocks in the BioMed industry include Gentium S.p.A (GENT), Genomic Health Inc. (GHDX) and Athersys, Inc. (ATHX). While Gentium and Genomic Health carry a Zacks Rank #1 (Strong Buy), Athersys has a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

GTX INC (GTXI): Free Stock Analysis Report


GENOMIC HEALTH INC (GHDX): Free Stock Analysis Report

ATHERSYS INC (ATHX): Free Stock Analysis Report

Zacks Investment Research